Furthermore, complement signaling-mediated activation of NF-κB in CD10+GPR77+ CAFs drives cancer stem cell (CSC) enrichment and chemoresistance through IL-6 and IL-8 paracrine secretion [347]. The gene discussed is NFKB1; the disease is cancer.